Vaksin VSV-EBOV (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vaksin VSV-EBOV" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

4^th place

13^th place

2,393^rd place

5,647^th place

1oxfordjournals.org

1,389^th place

721^st place

2^nd place

4^th place

5^th place

7^th place

7^th place

35^th place

1web.archive.org

1^st place

1^st place

1genengnews.com

low place

low place

1,266^th place

1,369^th place

doi.org

Marzi, Andrea; Ebihara, Hideki; Callison, Julie; Groseth, Allison; Williams, Kinola J.; Geisbert, Thomas W.; Feldmann, Heinz (2 Januari 2017). "Vesicular Stomatitis Virus–Based Ebola Vaccines With Improved Cross-Protective Efficacy". Journal of Infectious Diseases. 204 (suppl 3): S1066–S1074. doi:10.1093/infdis/jir348. ISSN 0022-1899. PMID 21987743. Diakses tanggal 3 January 2017.

genengnews.com

"Merck & Co. Licenses NewLink's Ebola Vaccine Candidate". GEN (dalam bahasa bahasa Inggris). 24 November 2014. Diarsipkan dari versi asli tanggal 2018-05-18. Diakses tanggal 3 Januari 2017.

nih.gov

ncbi.nlm.nih.gov

Trad, MA; Naughton, W; Yeung, A; Mazlin, L; O'sullivan, M; Gilroy, N; Fisher, DA; Stuart, RL (January 2017). "Ebola virus disease: An update on current prevention and management strategies". Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 86: 5–13. PMID 27893999.
Henao-Restrepo, AM; et al. (23 December 2016). "Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)" (PDF). Lancet (London, England). PMID 28017403.
Geisbert, TW (22 December 2016). "First Ebola virus vaccine to protect human beings?". Lancet (London, England). PMID 28017402.
Marzi, Andrea; Ebihara, Hideki; Callison, Julie; Groseth, Allison; Williams, Kinola J.; Geisbert, Thomas W.; Feldmann, Heinz (2 Januari 2017). "Vesicular Stomatitis Virus–Based Ebola Vaccines With Improved Cross-Protective Efficacy". Journal of Infectious Diseases. 204 (suppl 3): S1066–S1074. doi:10.1093/infdis/jir348. ISSN 0022-1899. PMID 21987743. Diakses tanggal 3 January 2017.

nytimes.com

Grady, Denise (23 Oktober 2014). "Ebola Vaccine, Ready for Test, Sat on the Shelf". nytimes.com (dalam bahasa bahasa Inggris). Diakses tanggal 3 Januari 2017.

oxfordjournals.org

jid.oxfordjournals.org

Marzi, Andrea; Ebihara, Hideki; Callison, Julie; Groseth, Allison; Williams, Kinola J.; Geisbert, Thomas W.; Feldmann, Heinz (2 Januari 2017). "Vesicular Stomatitis Virus–Based Ebola Vaccines With Improved Cross-Protective Efficacy". Journal of Infectious Diseases. 204 (suppl 3): S1066–S1074. doi:10.1093/infdis/jir348. ISSN 0022-1899. PMID 21987743. Diakses tanggal 3 January 2017.

thelancet.com

Henao-Restrepo, AM; et al. (23 December 2016). "Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)" (PDF). Lancet (London, England). PMID 28017403.

umn.edu

cidrap.umn.edu

"Ebola vaccine highly effective in final trial results". CIDRAP (dalam bahasa bahasa Inggris). Diakses tanggal 3 Januari 2017.

web.archive.org

"Merck & Co. Licenses NewLink's Ebola Vaccine Candidate". GEN (dalam bahasa bahasa Inggris). 24 November 2014. Diarsipkan dari versi asli tanggal 2018-05-18. Diakses tanggal 3 Januari 2017.

worldcat.org

Marzi, Andrea; Ebihara, Hideki; Callison, Julie; Groseth, Allison; Williams, Kinola J.; Geisbert, Thomas W.; Feldmann, Heinz (2 Januari 2017). "Vesicular Stomatitis Virus–Based Ebola Vaccines With Improved Cross-Protective Efficacy". Journal of Infectious Diseases. 204 (suppl 3): S1066–S1074. doi:10.1093/infdis/jir348. ISSN 0022-1899. PMID 21987743. Diakses tanggal 3 January 2017.